Reproductive Sciences

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

http://mc.manuscriptcentral.com/rsci

Click here for free access to the SAGE eReference platform!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, S.-F.
Right arrow Articles by Hsieh, Y.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, S.-F.
Right arrow Articles by Wang, P.-H.
Right arrow Articles by Lin, L.-Y.
Right arrow Articles by Ko, J.-L.
Right arrow Articles by Chen, G.-D.
Right arrow Articles by Yang, J.-S.
Right arrow Articles by Lee, H.-S.
Right arrow Articles by Hsieh, Y.-S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Reproductive Sciences, Vol. 14, No. 7, 710-718 (2007)
DOI: 10.1177/1933719107307916

A Significant Elevation of Plasma Level of Matrix Metalloproteinase—9 in Patients With High-Grade Intraepithelial Neoplasia and Early Squamous Cell Carcinoma of the Uterine Cervix

Shun-Fa Yang, PhD

Institute of Medicine Chung Shan Medical University, Taichung, Taiwan, ysf{at}csmu.edu.tw

Po-Hui Wang, MD, PhD

Institute of Medicine Chung Shan Medical University, Taichung, Taiwan, School of Medicine Chung Shan Medical University, Tachung, Taiwan, Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung, Taiwan

Long-Yau Lin, MD, PhD

Institute of Medicine Chung Shan Medical University, Taichung, Taiwan, School of Medicine Chung Shan Medical University, Tachung, Taiwan, Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung, Taiwan

Jiunn-Liang Ko, PhD

Institute of Medical and Molecular Toxicology Chung Shan Medical University. Tachung, Taiwan

Gin-Den Chen, MD

School of Medicine Chung Shan Medical University, Tachung, Taiwan, Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung, Taiwan

Jia-Sin Yang, MS

Institute of Medicine Chung Shan Medical University, Taichung, Taiwan,

Hong-Shen Lee, PhD

Institute of Medicine Chung Shan Medical University, Taichung, Taiwan

Yih-Shou Hsieh, PhD

Institute of Biochemistry and Biotechnology Chung Shan Medical University, Taichung, Taiwan

The objective of this article is to study the correlation between plasma levels of matrix metalloproteinase—2 and —9 (MMP-2 and MMP-9) and multisteps of cervical carcinogenesis as well as to evaluate their clinical application. Two hundred one blood samples were collected from 52 patients with early cervical squamous cell carcinoma (SCC), 41 with high-grade cervical intraepithelial neoplasia (CIN), 27 with low-grade CIN, and 81 healthy individuals. Enzyme-linked immunosorbent assay was used to detect plasma MMP-2 and MMP-9 concentrations. Gelatin zymography was used to directly compare the activities of MMP-2 and MMP-9 and to measure the MMP-9:MMP-2 ratio. A receiver-operating characteristic curve was plotted to determine the plasma cuto f levels of these biomarkers. Patients with low- and high-grade CIN were found to have significantly di ferent plasma MMP-9 levels (P < .001) but not MMP-2 levels. The cuto f values of 103.8 ng/mL for plasma MMP-9 and 0.70 for the MMP-9:MMP-2 ratio were used to distinguish SCC and high-grade CIN from low-grade CIN and healthy cases. The sensitivities and negative predictive values of these cuto f points were high (75.6% and 75.8% for MMP-9; 79.6% and 79.8% for the MMP-9:MMP-2 ratio). A significant elevation of plasma MMP-9 levels and the MMP-9:MMP-2 ratio in high-grade CIN and SCC patients manifests a stage point of high-grade CIN in cervical carcinogenesis and can be used as additional molecular information. Once plasma MMP-9 levels fall below 103.8 ng/mL or the MMP-9:MMP-2 ratio falls below 0.70, patients have only about a 20% chance of developing these cervical lesions.

Key Words: Plasma matrix metalloproteinase-9 • plasma MMP-9:MMP-2 ratio • high-grade cervical intraepithelial neoplasia • squamous cell carcinoma • cutoff level.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?